Published

Rwanda: Gilead Sciences, Rwanda's Ministry of Health and Africa CDC Collaborate to Support Rwanda's Marburg Virus Disease Response With Antiviral Therapeutic Donation

Summary by allAfrica
Addis Ababa, Ethiopia, October 8, 2024 -- Gilead Sciences, Inc., in collaboration with Africa CDC and Rwanda's Ministry of Health, has donated 5,100 vials of remdesivir to support Rwanda's response to the Marburg Virus Disease (MVD). This emergency donation aims to provide treatment to those affected by the virus following negotiations led by Africa CDC.
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.